First, to investigate circCDYL-RBP interactions in BC, we performed RIP experiments using the three RBPs confirmed to interact with circCDYL in HepG2 and/or K562: IGF2BP1, IGF2BP2, and GRWD1, in BC FL3 cells. The gene discussed is IGF2BP1; the disease is breast cancer.